Future research should explore other potential CRGs related to cuproptosis, investigate the functional roles of the four CRGs, especially DLAT, in HER-2-positive BRCA, and examine DLAT’s impact on anti-tumor immunity in these patients. The gene discussed is ERBB2; the disease is neoplasm.